Medication-Assisted Treatment (MAT) combines FDA-approved medications with counseling and behavioral therapies to treat opiate use disorder. According to SAMHSA, MAT is the gold standard for opiate recovery — reducing overdose deaths, improving treatment retention, and supporting long-term sobriety.
Why MAT Works
Opiate use disorder is a chronic brain disease. MAT addresses the underlying neurological changes caused by prolonged opiate use, reducing cravings and withdrawal symptoms so people can focus on rebuilding their lives. Research shows MAT reduces illicit drug use, overdose risk, criminal activity, and transmission of infectious diseases.
Buprenorphine (Suboxone)
Buprenorphine is a partial opioid agonist with a ceiling effect that limits euphoria and overdose risk. Suboxone combines buprenorphine with naloxone to deter injection misuse. It can be prescribed by certified physicians in office-based settings, making it highly accessible.
Methadone
Methadone is a full opioid agonist that prevents withdrawal symptoms and blocks the effects of other opiates. It must be dispensed through federally certified Opioid Treatment Programs. Methadone has decades of evidence supporting its effectiveness, particularly for severe long-term opiate dependence.
Naltrexone (Vivitrol)
Naltrexone is an opioid antagonist — it completely blocks opioid receptors. Available as a daily pill or monthly injection. No abuse potential. Requires complete detoxification before starting. Best suited for highly motivated individuals who have completed detox.
How Long Should MAT Continue
MAT duration should be individualized. Many guidelines recommend against arbitrary time limits. Research shows longer MAT duration is associated with better outcomes. For many people, MAT is a long-term treatment — similar to how diabetes or hypertension are managed with ongoing medication.
Leave a Reply